Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2026-04-17

Clinical Trial Update: The Use of Genex in the Management of Early-Stage Osteonecrosis of the Femoral Head

View source ↗

Summary

The Cleveland Clinic-sponsored trial evaluating Genex for early-stage osteonecrosis of the femoral head is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Genex

Snippet

Sponsor: The Cleveland Clinic | Conditions: Avascular Necrosis, Osteonecrosis | Status: ACTIVE_NOT_RECRUITING